Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Minasian

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancerMichael J Fisch, Ju-Whei Lee, Matthias Weiss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2022
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical TrialsJoseph M Unger, Riha Vaidya, Kathy S Albain, et al.
Breast Cancer Research and Treatment|August 31, 2018
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)Sherry Shen, Joseph M Unger, Katherine D Crew, et al.
Gynecologic Oncology|August 5, 2020
Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatmentJung-Min Lee, Christina M Annunziata, John L Hays, et al.
Clinical Trials (London, England)|December 1, 2005
Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Elise D Cook, Sarah Moody-Thomas, Karen B Anderson, et al.
CA: a Cancer Journal for Clinicians|March 22, 2024
Cancer screening with multicancer detection tests: A translational science reviewWendy S Rubinstein, Christos Patriotis, Anthony Dickherber, et al.
Journal of the National Cancer Institute|July 12, 2013
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trialTheodore M Brasky, Amy K Darke, Xiaoling Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927Dawn L Hershman, Joseph M Unger, Katherine D Crew, et al.
Cancer Epidemiology|June 25, 2018
The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trialsJoseph M Unger, William E Barlow, Catherine M Tangen, et al.
The New England Journal of Medicine|May 28, 2004
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliterIan M Thompson, Donna K Pauler, Phyllis J Goodman, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancerMichael J Fisch, Ju-Whei Lee, Matthias Weiss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2022
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical TrialsJoseph M Unger, Riha Vaidya, Kathy S Albain, et al.
Breast Cancer Research and Treatment|August 31, 2018
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)Sherry Shen, Joseph M Unger, Katherine D Crew, et al.
Gynecologic Oncology|August 5, 2020
Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatmentJung-Min Lee, Christina M Annunziata, John L Hays, et al.
Clinical Trials (London, England)|December 1, 2005
Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Elise D Cook, Sarah Moody-Thomas, Karen B Anderson, et al.
CA: a Cancer Journal for Clinicians|March 22, 2024
Cancer screening with multicancer detection tests: A translational science reviewWendy S Rubinstein, Christos Patriotis, Anthony Dickherber, et al.
Journal of the National Cancer Institute|July 12, 2013
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trialTheodore M Brasky, Amy K Darke, Xiaoling Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927Dawn L Hershman, Joseph M Unger, Katherine D Crew, et al.
Cancer Epidemiology|June 25, 2018
The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trialsJoseph M Unger, William E Barlow, Catherine M Tangen, et al.
The New England Journal of Medicine|May 28, 2004
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliterIan M Thompson, Donna K Pauler, Phyllis J Goodman, et al.
Pageof 18